Literature DB >> 2307454

A new glucose-6-phosphate dehydrogenase variant with congenital nonspherocytic hemolytic anemia (G6PD Genova). Biochemical characterization and mosaicism expression in the heterozygote.

G F Gaetani1, S Galiano, C Melani, M Miglino, G L Forni, G Napoli, L Perrone, A M Ferraris.   

Abstract

A new deficient variant of glucose-6-phosphate dehydrogenase (G6PD) causing severe congenital nonspherocytic hemolytic anemia (CNSHA) is described. The variant enzyme, characterized by slow electrophoretic mobility, extreme in vivo and in vitro lability, high Km for G6P and strongly acidic pH optimum, appears to be unique, and has been designated G6PD Genova. Investigation of an obligate heterozygote using various cytochemical, biochemical and recombinant-DNA techniques showed G6PD mosaicism in the erythrocytes and leukocytes. Therefore, the presence of a disadvantageous mutation at one Gd locus did not determine selection in favor of the normal allele in the heterozygote's hemopoietic cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2307454     DOI: 10.1007/bf00196229

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  23 in total

1.  Congenital nonspherocytic hemolytic anemia.

Authors:  H N KIRKMAN; H D RILEY
Journal:  Am J Dis Child       Date:  1961-09

2.  Glucose 6-phosphate dehydrogenase deficiency and incidence of hematologic malignancy.

Authors:  A M Ferraris; G Broccia; T Meloni; G Forteleoni; G F Gaetani
Journal:  Am J Hum Genet       Date:  1988-03       Impact factor: 11.025

3.  A clonal complete remission in a patient with acute nonlymphocytic leukemia originating in a multipotent stem cell.

Authors:  R J Jacobson; M J Temple; J W Singer; W Raskind; J Powell; P J Fialkow
Journal:  N Engl J Med       Date:  1984-06-07       Impact factor: 91.245

4.  Red cell NADP+ and NADPH in glucose-6-phosphate dehydrogenase deficiency.

Authors:  H N Kirkman; G D Gaetani; E H Clemons; C Mareni
Journal:  J Clin Invest       Date:  1975-04       Impact factor: 14.808

5.  Clonal evolution in human lymphoblast cultures.

Authors:  B R Migeon; J Axelman; G Stetten
Journal:  Am J Hum Genet       Date:  1988-05       Impact factor: 11.025

6.  Anemia, cataracts, and seizures in patient with glucose-6-phosphate dehydrogenase deficiency.

Authors:  D W Westring; A V Pisciotta
Journal:  Arch Intern Med       Date:  1966-10

7.  Severe-glucose-6-phosphate dehydrogenase (G6PD) deficiency associated with chronic hemolytic anemia, granulocyte dysfunction, and increased susceptibility to infections: description of a new molecular variant (G6PD Barcelona).

Authors:  J L Vives Corrons; E Feliu; M A Pujades; F Cardellach; C Rozman; A Carreras; J M Jou; M T Vallespí; F J Zuazu
Journal:  Blood       Date:  1982-02       Impact factor: 22.113

8.  Molecular cloning and nucleotide sequence of cDNA for human glucose-6-phosphate dehydrogenase variant A(-).

Authors:  A Hirono; E Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

9.  A new glucose-6-phosphate dehydrogenase variant, Gd(-) Tepic, characterized by moderate enzyme deficiency and mild episodes of hemolytic anemia.

Authors:  R Lisker; R Pérez-Briceño; E Beutler
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

10.  Diverse point mutations in the human glucose-6-phosphate dehydrogenase gene cause enzyme deficiency and mild or severe hemolytic anemia.

Authors:  T J Vulliamy; M D'Urso; G Battistuzzi; M Estrada; N S Foulkes; G Martini; V Calabro; V Poggi; R Giordano; M Town
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

View more
  1 in total

1.  Somatic-cell selection is a major determinant of the blood-cell phenotype in heterozygotes for glucose-6-phosphate dehydrogenase mutations causing severe enzyme deficiency.

Authors:  S Filosa; N Giacometti; C Wangwei; D De Mattia; D Pagnini; F Alfinito; F Schettini; L Luzzatto; G Martini
Journal:  Am J Hum Genet       Date:  1996-10       Impact factor: 11.025

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.